산조인탕치료가 여성갱년기 수면장애에 미치는 효과 : 체계적 문헌고찰 및 메타분석
Sanjoin-tang (Suanzaoren decoction) for Insomnia in Menopausal Syndromes: A Systematic Review and Meta-analysis
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives : The purpose of this systematic review was to investigate the efficacy and safety of Sanjointang (Suanzaoren decoction, SZRD) for insomnia in menopausal syndromes. Method : We searched the following databases: PubMed, Cochrane Library, EMBASE, China National Knowledge Infrastructure (CNKI), Chinese Science and Technique Journals Database (VIP), Wanfang, Research Information Service System (RISS), OASIS, Korean studies Information Service System (KISS), and National Digital Science Library (NDSL) databases. Randomized controlled trials (RCTs) or quasi-RCTs that used SZRD for women in menopause were included. The methodological quality of each RCT was assessed using the risk of bias tool. Results : In total, nine RCTs were finally included. The included RCTs had a high risk of bias across their domains. Three RCTs examined the effects of SZRD compared with western medicine (WM) in insomnia. Three RCTs showed favorable effects of SZRD with insomnia. Infrastructure also showed that SZRD resulted in better clinical WM (RR 1.19, 95% CI 1.07 to 1.32, P=0.001, I2=0%). Four RCTs showed favorable effects of Modified SZRD with insomnia. Infrastructure also showed that Modified SZRD resulted in better clinical WM (RR 1.13, 95% CI 1.04 to 1.23, P=0.004, I2=0%). Among the 4 RCTs, three RCTs showed an equivalent effect on the total Pittsburh Sleep Quality Index (PSQI). The meta-analysis also showed that Modified SZRD had a superior effect on the total of PSQI (total of PSQI : MD -2.55, 95% CI -3.72 to -1.37, P<0.0001, I2=85%). Only 2 trials reported adverse events and none reported severe adverse events. Conclusion : SZRD appears to be safe, but there is insufficient evidence to make a definitive conclusion because only a few studies reported adverse events. Due to the poor methodological quality of the included studies and the small number of trials included, the evidence cannot be reproduced and assessed. Welldesigned RCTs with a larger sample size are needed in the future.
Abstract
Objectives : The purpose of this systematic review was to investigate the efficacy and safety of Sanjointang (Suanzaoren decoction, SZRD) for insomnia in menopausal syndromes. Method : We searched the following databases: PubMed, Cochrane Library, EMBASE, China National Knowledge Infrastructure (CNKI), Chinese Science and Technique Journals Database (VIP), Wanfang, Research Information Service System (RISS), OASIS, Korean studies Information Service System (KISS), and National Digital Science Library (NDSL) databases. Randomized controlled trials (RCTs) or quasi-RCTs that used SZRD for women in menopause were included. The methodological quality of each RCT was assessed using the risk of bias tool. Results : In total, nine RCTs were finally included. The included RCTs had a high risk of bias across their domains. Three RCTs examined the effects of SZRD compared with western medicine (WM) in insomnia. Three RCTs showed favorable effects of SZRD with insomnia. Infrastructure also showed that SZRD resulted in better clinical WM (RR 1.19, 95% CI 1.07 to 1.32, P=0.001, I2=0%). Four RCTs showed favorable effects of Modified SZRD with insomnia. Infrastructure also showed that Modified SZRD resulted in better clinical WM (RR 1.13, 95% CI 1.04 to 1.23, P=0.004, I2=0%). Among the 4 RCTs, three RCTs showed an equivalent effect on the total Pittsburh Sleep Quality Index (PSQI). The meta-analysis also showed that Modified SZRD had a superior effect on the total of PSQI (total of PSQI : MD -2.55, 95% CI -3.72 to -1.37, P<0.0001, I2=85%). Only 2 trials reported adverse events and none reported severe adverse events. Conclusion : SZRD appears to be safe, but there is insufficient evidence to make a definitive conclusion because only a few studies reported adverse events. Due to the poor methodological quality of the included studies and the small number of trials included, the evidence cannot be reproduced and assessed. Welldesigned RCTs with a larger sample size are needed in the future.
참고문헌 (26)
- Takahashi TA, "Menopause", Med Clin North Am, 99(3), pp.521~534 (2015)
- 김영혜, "중년여성의 폐경증상과 삶의 질", Journal of Korean Academy of Nursing, 33(5), pp.601~608 (2003), 한국간호과학회
- Shin C, "Prevalence of insomnia and its relationship to menopausal status in middleaged Korean women", Psychiatry Clin Neurosci, 59(4), pp.395~402 (2005)
- Holmberg L, "Increased risk of recurrence after hormone replacement therapy in breast cancer survivors", J Natl Canc Inst, 100(7), pp.475~482 (2008)
- Nelson HD, "Commonly used types of postmenopausal estrogen for treatment of hot flashes scientific review", JAMA, 291(13), pp.1610~1620 (2004)
- Cheng B, "Complementary and alternative medicine for the treatment of insomnia: an overview of scientific evidence from 2008 to 2018", Curr Vasc Pharmacol (2019)
- Singh A, "Treatment of insomnia with traditional chinese herbal medicine", Int Rev Neurobiol, 135, pp.97~115 (2017)
- Zhu XS, "Chinese herbal medicine for menopausal symptoms", Cochrane Database Syst Rev, 3 (2016)
- Yeh CH, "Suan zao ren tang as an original treatment for sleep difficulty in climacteric women : a prospective clinical observation", Evid Based Complement Alternat Med, 2011, pp.673813~ (2011)
- Jiang JG, "Separation and purification of saponins from semen ziziphus jujuba and their sedative and hypnotic effects", J Pharm Pharmacol, 59(8), pp.1175~1180 (2007)
- Zhou QH, "Suanzaoren formulae for insomnia : updated clinical evidence and possible mechanisms", Front Pharmacol, 9, pp.76~ (2018)
- Xie CL, "Efficacy and safety of Suanzaoren decoction for primary insomnia: a systematic review of randomized controlled trials", BMC Complement Altern Med, 13, pp.18~ (2013)
- Nie HY, "Systematic evaluation of the therapeutic effect of modified suanzaoren decoction and western medicine on menopausal insomnia", Pract Clin J Integr Tradit Chin Western Med, 15(12), pp.22~24 (2015)
- Higgins JPT, "Cochrane handbook for systematic reviews of interventions. Version 5.1.0" (2011), The Cochrane Collaboration
- Yang GH, "Observation on the therapeutic effect of suanzaoren decoction on insomnia of female menopause", Yixue Meixue Meirong, 24(4), pp.313~314 (2015)
- Li K, "Modified suanzaorentang 56 cases improve the quality of sleep in patients with insomnia menopause effectiveness analysis", Systems Med, 1(2), pp.31~33 (2016)
- Zhang Y, "Analysis of the effect of suanzaoren decoction on insomnia of female menopause", Med Diet Health, (6), pp.148~ (2018)
- Hou JX, "Study on the clinical experience of the treatment of internal emergency with the combination of chinese and western medicine", Special Health, (19), pp.252~253 (2018)
- Li QA, "Observation on the therapeutic effect of suanzaoren decoction on insomnia in menopause", China Prac Med., 8(7), pp.154~155 (2013)
- Yao LN, "Clinical effect of suanzaoren decoction on insomnia in menopause", Family Therapist, 12(1), pp.344~345 (2015)
- Zhao GP, "Efficacy observation of semen ziziphi spinosae decoction on climacteric insomnia", Shanxi TCM, 33(2), pp.20~22 (2017)
- Zhou Q, "Curative Effect Observation of Modified Suanzaoren Decoction on Menopausal Insomnia", Liaoning TCM, 40(6), pp.1165~1166 (2013)
- Zheng J, "Clinical efficacy of suanzaorentang (a traditional chinese medicine patent prescription)in treatment of 60 patients with menopause insomnia", Chin J School Doctor, 31(7), pp.522~523 (2017)
- 장인수, "최근 독성 문제가 제기된 한약재에 대한 고찰", 대한한의학회지, 28(1), pp.1~10 (2007), 대한한의학회
- Schulz KF, "CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials", BMJ, 340, pp.c332~ (2010)
- Cheng CW, "CONSORT extension for chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration", Ann Intern Med, 167(2), pp.112~121 (2017)